A phase II trial of second line Axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma (HCC)

Mairead Mcnamara, LW Le, AM Horgan, A Aspinall, KW Burak, N Dhani, E Chen, M Sinaei, G Lo, TK Kim, P Rogalla, O Bathe, JJ Knox

    Research output: Contribution to conferencePoster

    Fingerprint

    Dive into the research topics of 'A phase II trial of second line Axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma (HCC)'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology